Vincent Ling, Ph.D,  established Iridium Biosciences LLC in 2009 to transform biotechnology ideas into commercializable products.  As the founder, he provided executive discovery services to major pharmaceuticals including Wyeth, Pfizer and GSK.  A seasoned biotechnologist with over 20 years of industrial experience in domestic and international settings,  Dr. Ling is an expert in the design of biologics drug discovery systems, specializing in optimizing protein therapeutics and molecular evolution platforms.  

          Dr. Ling currently serves as Head of Biological Sciences at Neurotech (RI).

   Bibliography                                   This page will redirect to LinkedIn in 20 seconds